Cholangiocarcinoma, also known as bile duct cancer, is a rare disease. It's a devastating condition incurable at the point ...

Intraductal neoplasms of the bile duct are macroscopically characterized by exophytic or polypoid growth patterns and have a favorable prognosis. Although some tumors with a predominantly tubular ...

肝内胆管癌(intrahepatic cholangiocarcinoma, iCCA)的预后不佳，很大原因是由于诊断不够及时造成的，因此iCCA的早期诊断和及早治疗是提高疾病治愈效果的 ...

Cholangiocarcinoma is a relatively rare adenocarcinoma of the bile ducts that is rapidly fatal unless it can be completely resected. In most cases, the tumor is too advanced for resection by the ...

With a baby on the way, Nathan Kirkland was facing a rare, aggressive form of bile duct cancer. Kirkland’s bills piled up as ...

Intrahepatic cholangiocarcinoma (IHCCA), a global health problem, is increasing in incidence and has differing etiologies worldwide. Next-generation sequencing (NGS) is rapidly being incorporated into ...

Across the 3 cholangiocarcinoma subtypes, OS of more than 3 years was associated with lower percentages of PD-1+ cells among the CD8+ T cells than those with OS of less than 3 years.

The “ubiquitous dependency” of cholangiocarcinoma on CDK4/6 activity, Kongpetch said, suggests that the that the CDK4/6-pRB pathway could be a treatable target.

Results showed that across 3,038 U.S. counties there were 85,909 cholangiocarcinoma cases and 23,902 cholangioscopies performed — an annual mean volume of 2.5 (standard deviation, 7.1 ...

Cholangiocarcinoma is a rare type of cancer, with approximately 8,000 people in the United States receiving a diagnosis each year, according to the American Cancer Society. FGFR2 fusions or ...

Cholangiocarcinoma: New organ-on-chip aims at accelerating research and personalized medicine A multidisciplinary team of researchers from Politecnico di Milano and Humanitas has developed a three ...